In this study, clinical and laboratory findings were tested for correlation with the presence of Clostridium difficile. The toxigenicity of the isolated strains and the toxins were determined in faecal samples of immunocompromised children admitted to a single room for protective isolation. Using the toxin assay as the gold standard, the culture sensitivity of toxigenic C difficile was 94-1%, the specificity 93/8%, the positive predictive value 62*8%, and the negative predictive value 99X3%. Correction for stools with a positive culture of toxigenic C difficile preceding detection of toxin, resulted in a positive prediction value of 78*4%. A statistically significant association was found between a positive faecal toxin assay and fever, and between a positive culture of toxigenic C difficile and abdominal pain: 42% of the patients with positive toxin assays had fever versus 21% with negative toxin assays, and 66% of the patients with a positive culture for toxigenic C difficile had abdominal pain, versus 22% with negative cultures. Further analysis of the cultures and toxin assays showed no statistically significant association with diarrhoea, fever, white blood cell count, C reactive protein concentrations, or abdominal pain. Based on these findings, it is suggested that immunocompromised children should be treated when toxigenic C difficile is cultured or when toxin is detected in stool samples. (Gut 1994; 35: 1608-1612 Since 1978 Clostridium difficile has been recognised as an important cause of antibiotic associated colitis. This disease is caused by the two toxins produced by C difficile, toxin A and toxin B (for review see Lyerly et al).I Nontoxigenic strains of C dfficile cannot produce any toxin because they lack the genes encoding for both toxin A and toxin B.24
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The role of C difficile as a cause of diarrhoea in neonates and infants has been the subject of many studies. There is a high incidence (up to 25-50%) of asymptomatic colonisation of both toxigenic and non-toxigenic C difficile strains in neonates and infants.5-7 It seems that, especially during the first six months of life, the gut is insensitive to the toxins produced by C difficile. Several are clearly difficult to use in this age group. Presumptive diagnosis is dependent on the isolation of toxigenic C difficile or the finding of toxin A or toxin B, or both, in the stools. Children with haematological malignancies are a special group with respect to the clinical significance of colonisation by C difficile. On the one hand they are at risk for developing antibiotic associated diarrhoea because they are often admitted to hospital because of the underlying disease or cancer chemotherapy, while on the other hand they are treated with multiple courses of antimicrobial agents. Furthermore, these children can develop diarrhoea for a number of other reasons, for example, chemotherapy.
In a previous study we showed a high incidence of C difficile in this infant subgroup.
In this study we looked at the clinical significance of the presence of C difficile. In total 343 faecal samples were collected; toxigenic C difficile was cultured from 55 samples, while in 39 cases non-toxigenic C difficile was cultured and 249 samples were negative. The toxin assay was evaluable for 339 of 343 samples (in four samples with a positive culture of toxigenic C difficile, the toxin assay was not performed); 34 samples were positive. The toxin assay was positive in 62% (32 of 51) of the samples from which toxigenic C difficile could be isolated and in only 0.8% (2 of 288) of stools from which no toxigenic C difficile could be isolated. When the toxin assay was used as the gold standard and compared with the culture of toxigenic isolates, the sensitivity of culture was 94 1%, the specificity 93.8%, (9) 15 (12) *At least one culture had to be positive during the observation period; tonly two patients were cytotoxin positive and culture negative, the others were both culture and toxin positive.
As Table I shows, during 29 of a total of 78 admissions (37%), there was evidence for the presence of C difficile by culture or cytotoxin assay, or both. These comprised 16 patients with at least one positive culture and 13 patients with at least one positive toxin assay, of whom 11 were also culture positive. During 66 admissions to this ward antimicrobial treatment was given and during 35 admissions cancer chemotherapy. During eight admissions neither antimicrobial treatment nor cancer chemotherapy was given; however, seven of these eight patients received antibiotics or chemotherapy in the preceding period. One way ANOVA showed a significant group effect, as defined in Table I , on duration of admission to the ward (F(2-75)= 10-03, p<001) and on age of the patients (F(2-75)=4-06, p<005). Separate t tests showed significant differences between the presence of toxin in stool samples and the absence of both toxins and C difficile for the duration of the admission (t=2-24, degrees of freedom= 12 1, p<005); respectively the presence of C difficile but not its toxin, and the absence of both for age (t=2.93, degrees of Antimicrobial treatment (/o) (n) 82 (46) 67 (6) 92 (12) 82 (64) Selective gut decontamination (%) (n) 48 (27) 33 (3) 85 (11) 53 (41) Cancer chemotherapy (0/,) (n) 41 (23) 44 (4) 62 (8) 45 (35) Immunocompromised (0/6) (n) 68 (38) 78 (7) 85 (11) 72 (56) Treatment for antibiotic associated diarrhoea (%) (n) 2 (1) 22 (2) 69 (9) 15 (12) *At least one culture had to be positive during the observation period; tonly two patients were cytotoxin positive and culture negative, the others were both culture and toxin positive. degrees of freedom=2, p<O000 1).
In Table II the same demographic data are shown, however, non-toxigenic C difficile strains are categorised in the culture negative group. Statistical analysis of these groups showed the same statistically significant associations as mentioned in Table I , except that one way ANOVA showed no significant group effect on the age of patients. Tables III, IV , and V show relations between the different groups and diarrhoea, fever, white blood cell count (WBC), C reactive protein values, and abdominal pain. The data are evaluated for the overall culture results, including toxigenic as well as non-toxigenic strains (Table III) , culture of toxigenic C difficile (Table IV) , and positive toxin assays (Table  V) . From these Tables it is clear that there are statistically significant associations between a positive faecal toxin assay and fever and a positive culture of toxigenic C difficile and abdominal pain: 42% of the patients with a positive toxin assay had fever versus 21% with a negative toxin assay, 66% of the patients with a positive culture for toxigenic C difficile had abdominal pain, while only 22% with negative cultures showed this symptom. Even though this culture scored very well, too many positive samples were found compared with the gold standard of the toxin assay. Nevertheless, several studies have shown that patients with negative toxin assays and positive cultures are related to antibiotic associated diarrhoea.3' 32 In this study a positive culture of toxigenic C difficile preceded detection of toxin in three of 13 patients (23%). If these stools are considered toxin positive, the outcome of the positive prediction value can be raised to 78f4% and the positive likelihood ratio to 25-8. The significant group effect on age found in Table I was lost in Table II . Stools from which non-toxigenic C difficile strains were isolated, were considered culture negative in Table II, showing that non-toxigenic C difficile strains are predominantly isolated in the younger age groups. This phenomenon has been confirmed by numerous other studies.33-36 Group effects of the presence of toxin on admission time and the use of selective gut decontamination (Tables I and II) can be explained because children who are admitted for a longer time, are at risk for a longer time and are probably sicker and in need of selective gut decontamination because of severe immunosuppression.
In conclusion, we established a statistically significant association between a positive faecal toxin assay and fever, and between a positive culture of toxigenic C difficile and abdominal pain. This clearly suggests that toxigenic C difficile is a cause of disease in immunocompromised children.
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